TEAM-NB Position Paper Helps Manufacturers Manage And Benefit From Off-Label Use
Executive Summary
Off-label use of otherwise regulated medical devices is not legal but it happens. The EU’s latest position paper on this topic takes a pragmatic approach that aims to support manufacturers, clinicians and patients.
You may also be interested in...
Why EU Patients Need Regulation That Aids Access To Orphan Devices
Children and patients with rare diseases across the world need better access to medical devices, but new EU regulation fails to support manufacturers of such products. A recent journal article highlights why orphan devices are vital and the need for improved regulation.
EU Guidance Details When In-House Devices Are Exempt From MDR and IVDR
Another MDCG guidance document is out. It elaborates on Article 5(5) of the new EU medtech regulations, which spares devices made and used in health institutions from needing to conform with most MDR/IVDR requirements.
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.